The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 17, 2015

Filed:

Feb. 16, 2011
Applicants:

William F. Kaemmerer, Edina, MN (US);

Michael D. Kaytor, Maplewood, MN (US);

Inventors:

William F. Kaemmerer, Edina, MN (US);

Michael D. Kaytor, Maplewood, MN (US);

Assignee:

Medtronic, Inc., Minneapolis, MN (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07H 21/04 (2006.01); A61F 15/00 (2006.01); A61K 9/00 (2006.01); A61K 31/7052 (2006.01); A61K 31/713 (2006.01); A61K 48/00 (2006.01); A61M 37/00 (2006.01); C12N 15/11 (2006.01); C12N 15/113 (2010.01); A61M 25/00 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0085 (2013.01); A61K 31/7052 (2013.01); A61K 31/713 (2013.01); A61K 48/00 (2013.01); A61K 48/0075 (2013.01); A61M 37/00 (2013.01); C12N 15/111 (2013.01); C12N 15/113 (2013.01); A61M 25/00 (2013.01); A61M 2210/0693 (2013.01); C12N 2310/111 (2013.01); C12N 2310/14 (2013.01); C12N 2310/53 (2013.01); C12N 2320/32 (2013.01);
Abstract

The present invention provides devices, small interfering RNAs, and methods for treating a neurodegenerative disorder comprising the steps of surgically implanting a catheter so that a discharge portion of the catheter lies adjacent to a predetermined infusion site in a brain, and discharging through the discharge portion of the catheter a predetermined dosage of at least one substance capable of inhibiting production of at least one neurodegenerative protein. The present invention also provides valuable small interfering RNA vectors, systems, and methods for treating Huntington's disease in vivo without impairment of cell endoplasmic reticulum, spontaneous motor activity, or locomotor activity of a patient.


Find Patent Forward Citations

Loading…